Laurence Gruer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Laurence Gruer has a total of 240 co-authors. Here are the top co-authors by number of shared publications:
Lawrence Elliott
5 shared publications- Gail Gilchrist
National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience King's College London London UK
4 shared publications J. Etienne
Laboratoire de Bactériologie (Prof J. Fleurette), Hôpital Cardiologique Louis Pradel et Faculté de Médecine Alexis Carrel Rue Guillaume Paradin, 69372 Lyon Cédex 8, France
4 shared publicationsJ. Fleurette
Laboratoire de Bactériologie (Prof J. Fleurette), Hôpital Cardiologique Louis Pradel et Faculté de Médecine Alexis Carrel Rue Guillaume Paradin, 69372 Lyon Cédex 8, France
4 shared publicationsAnita Morrison
3 shared publicationsAvril Taylor
Scottish Centre for Infection and Environmental Health, Glasgow
3 shared publications
Latest Publications
- Open Access
- 27 January 2021
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 31 (1) , 3-4
The Global Society on Migration, Ethnicity, Race and Health: why race can’t be ignored even if it causes discomfort
The first World Congress on Migration, Ethnicity, Race and Health took place in Edinburgh, Scotland in 2018, jointly hosted by the European Public Health Association (EUPHA) with the scientific abstracts published by the EJPH. 1 Migration, ethnicity and race are sensitive yet unavoidable topics in today’s globalized, multicultural societies. 2 Their impact on health and well-being is beyond doubt, but understanding how and why and addressing the consequent disparities and injustices are huge global challenges. The aim of the Congress was to bring together researchers, practitioners, community members, activists and policymakers from across the world who were working on at least one of these three intersecting health-related topics. It was driven by a vision that much would be gained by sharing information, insights and concerns and working together to improve the health of all. At the outset, there was a fierce debate about its name, in particular about whether to include the word race. Some argued it was a discredited concept. It was decided to retain it while providing Congress participants with a glossary of definitions for migration, ethnicity, race and other related words, aimed at creating a shared vocabulary and enhancing mutual understanding. 3
- 27 January 2021
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 31 (1) , 3-4
Open AccessThe Global Society on Migration, Ethnicity, Race and Health: why race can’t be ignored even if it causes discomfort
The first World Congress on Migration, Ethnicity, Race and Health took place in Edinburgh, Scotland in 2018, jointly hosted by the European Public Health Association (EUPHA) with the scientific abstracts published by the EJPH. 1 Migration, ethnicity and race are sensitive yet unavoidable topics in today’s globalized, multicultural societies. 2 Their impact on health and well-being is beyond doubt, but understanding how and why and addressing the consequent disparities and injustices are huge global challenges. The aim of the Congress was to bring together researchers, practitioners, community members, activists and policymakers from across the world who were working on at least one of these three intersecting health-related topics. It was driven by a vision that much would be gained by sharing information, insights and concerns and working together to improve the health of all. At the outset, there was a fierce debate about its name, in particular about whether to include the word race. Some argued it was a discredited concept. It was decided to retain it while providing Congress participants with a glossary of definitions for migration, ethnicity, race and other related words, aimed at creating a shared vocabulary and enhancing mutual understanding. 3
- Open Access
- 1 January 2021
- Published by Taylor & Francis in Global Health Action
- Vol. 14 (1) , 1938871
Neonatal mortality rates, characteristics, and risk factors for neonatal deaths in Ghana: analyses of data from two health and demographic surveillance systems
Reducing neonatal mortality rates (NMR) in developing countries is a key global health goal, but weak registration systems in the region stifle public health efforts.To calculate NMRs, investigate ...
- 1 January 2021
- Published by Taylor & Francis in Global Health Action
- Vol. 14 (1) , 1938871
Open AccessNeonatal mortality rates, characteristics, and risk factors for neonatal deaths in Ghana: analyses of data from two health and demographic surveillance systems
Reducing neonatal mortality rates (NMR) in developing countries is a key global health goal, but weak registration systems in the region stifle public health efforts.To calculate NMRs, investigate ...
- 1 August 2020
- Published by Elsevier in Public Health
- Vol. 185, 88-90
Test, test, test for COVID-19 antibodies: the importance of sensitivity, specificity and predictive powers
- 1 August 2020
- Published by Elsevier in Public Health
- Vol. 185, 88-90
Test, test, test for COVID-19 antibodies: the importance of sensitivity, specificity and predictive powers
- Open Access
- 1 May 2020
- Published by Elsevier in Public Health
- Vol. 182, 32-38
Ethnic variations in falls and road traffic injuries resulting in hospitalisation or death in Scotland: the Scottish Health and Ethnicity Linkage Study
- 1 May 2020
- Published by Elsevier in Public Health
- Vol. 182, 32-38
Open AccessEthnic variations in falls and road traffic injuries resulting in hospitalisation or death in Scotland: the Scottish Health and Ethnicity Linkage Study
- Open Access
- 1 August 2018
- Published by Elsevier in Public Health
- Vol. 161, 5-11
Differences in all-cause hospitalisation by ethnic group: a data linkage cohort study of 4.62 million people in Scotland, 2001–2013
- 1 August 2018
- Published by Elsevier in Public Health
- Vol. 161, 5-11
Open AccessDifferences in all-cause hospitalisation by ethnic group: a data linkage cohort study of 4.62 million people in Scotland, 2001–2013
- 1 December 2017
- Published by Elsevier in Public Health
- Vol. 153, 174-175
Re: Letter to the Editor of Public Health in response to ‘After 50 years and 200 papers, what can the Midspan cohort studies tell us about our mortality?’
- 1 December 2017
- Published by Elsevier in Public Health
- Vol. 153, 174-175
Re: Letter to the Editor of Public Health in response to ‘After 50 years and 200 papers, what can the Midspan cohort studies tell us about our mortality?’
- Open Access
- 1 January 2017
- Published by Elsevier in Public Health
- Vol. 142, 186-195
After 50 years and 200 papers, what can the Midspan cohort studies tell us about our mortality?
- 1 January 2017
- Published by Elsevier in Public Health
- Vol. 142, 186-195
Open AccessAfter 50 years and 200 papers, what can the Midspan cohort studies tell us about our mortality?
- Open Access
- 3 July 2013
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 178 (5) , 770-779
Does Smoking Reduction in Midlife Reduce Mortality Risk? Results of 2 Long-Term Prospective Cohort Studies of Men and Women in Scotland
A long-term cohort study of working men in Israel found that smokers who reduced their cigarette consumption had lower subsequent mortality rates than those who did not. We conducted comparable analyses in 2 populations of smokers in Scotland. The Collaborative Study included 1,524 men and women aged 40–65 years in a working population who were screened twice, in 1970–1973 and 1977. The Renfrew/Paisley Study included 3,730 men and women aged 45–64 years in a general population who were screened twice, in 1972–1976 and 1977–1979. Both groups were followed up through 2010. Subjects were categorized by smoking intensity at each screening as smoking 0, 1–10, 11–20, or ≥21 cigarettes per day. At the second screening, subjects were categorized as having increased, maintained, or reduced their smoking intensity or as having quit smoking between the first and second screenings. There was no evidence of lower mortality in all reducers compared with maintainers. Multivariate adjusted hazard ratios of mortality were 0.91 (95% confidence interval (CI): 0.75, 1.10) in the Collaborative Study and 1.08 (95% CI: 0.97, 1.20) in the Renfrew/Paisley Study. There was clear evidence of lower mortality among quitters in both the Collaborative Study (hazard ratio = 0.66, 95% CI: 0.56, 0.78) and the Renfrew/Paisley Study (hazard ratio = 0.75, 95% CI: 0.67, 0.84). In the Collaborative Study only, we observed lower mortality similar to that of quitters among heavy smokers (≥21 cigarettes/day) who reduced their smoking intensity. These inconclusive results support the view that reducing cigarette consumption should not be promoted as a means of reducing mortality, although it may have a valuable role as a step toward smoking cessation.
- 3 July 2013
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 178 (5) , 770-779
Open AccessDoes Smoking Reduction in Midlife Reduce Mortality Risk? Results of 2 Long-Term Prospective Cohort Studies of Men and Women in Scotland
A long-term cohort study of working men in Israel found that smokers who reduced their cigarette consumption had lower subsequent mortality rates than those who did not. We conducted comparable analyses in 2 populations of smokers in Scotland. The Collaborative Study included 1,524 men and women aged 40–65 years in a working population who were screened twice, in 1970–1973 and 1977. The Renfrew/Paisley Study included 3,730 men and women aged 45–64 years in a general population who were screened twice, in 1972–1976 and 1977–1979. Both groups were followed up through 2010. Subjects were categorized by smoking intensity at each screening as smoking 0, 1–10, 11–20, or ≥21 cigarettes per day. At the second screening, subjects were categorized as having increased, maintained, or reduced their smoking intensity or as having quit smoking between the first and second screenings. There was no evidence of lower mortality in all reducers compared with maintainers. Multivariate adjusted hazard ratios of mortality were 0.91 (95% confidence interval (CI): 0.75, 1.10) in the Collaborative Study and 1.08 (95% CI: 0.97, 1.20) in the Renfrew/Paisley Study. There was clear evidence of lower mortality among quitters in both the Collaborative Study (hazard ratio = 0.66, 95% CI: 0.56, 0.78) and the Renfrew/Paisley Study (hazard ratio = 0.75, 95% CI: 0.67, 0.84). In the Collaborative Study only, we observed lower mortality similar to that of quitters among heavy smokers (≥21 cigarettes/day) who reduced their smoking intensity. These inconclusive results support the view that reducing cigarette consumption should not be promoted as a means of reducing mortality, although it may have a valuable role as a step toward smoking cessation.
- 1 March 2012
- Published by Elsevier in Public Health
- Vol. 126 (3) , 179-184
World Congress of Epidemiology 2011: themes and highlights
- 1 March 2012
- Published by Elsevier in Public Health
- Vol. 126 (3) , 179-184
World Congress of Epidemiology 2011: themes and highlights
- 15 February 2012
- Published by Elsevier in Public Health
- Vol. 126 (3) , 227-229
Smoke-free legislation: Global reach, impact and remaining challenges
- 15 February 2012
- Published by Elsevier in Public Health
- Vol. 126 (3) , 227-229
Smoke-free legislation: Global reach, impact and remaining challenges